Trial By Error: My FOI Request to King’s College London; My Letter to Mahana Therapeutics

By David Tuller, DrPH Yesterday I sent a freedom-of-information request to King’s College London about the recently announced licensing deal it has with Mahana Therapeutics. The deal involves a web-based CBT program for irritable bowel syndrome, which I have written about here and here. This morning I sent a note to the e-mail address for […]

Source link

Related posts

Strategic deployment of feature-based attentional gain in primate visual cortex


A virus-acquired host cytokine controls systemic aging by antagonizing apoptosis


Lantern Pharma Selects REPROCELL Inc., for Drug Screening and Biomarker Discovery Services


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy